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Convection-enhanced delivery (CED) is a proven method for targeted drug delivery 
to the brain that circumvents the blood-brain barrier (BBB). Little study has been 
conducted in understanding CED in pathological brain states. This is of importance when 
dealing with chemotherapeutic agent delivery to brain tumors, where vasogenic edema 
(VE) exists. The current study aims to characterize a model of VE suitable for studying 
CED. 
VE was produced in the right hemisphere of the rat brain using multiple infusions 
of hyperosmotic mannitol(0.25mL/kg/s over 30 seconds) delivered through the right 
. . . 
Vl l l  
internal carotid artery. Magnetic resonance imaging (MRI) revealed consistent edema 
formation and high water levels in the ipsilateral gray and white matter within an hour of 
the first infusion. Evan's Blue (EB) staining verified that VE has formed. However, 
apparent diffusion coefficient (ADC) and histological examination revealed also that some 
possible cytotoxic edema formed. 
This model provides a reproducible technique for generating a large area of edema 
for CED study. Further studies with lower doses of mannitol, while titrating to changes in 
ADC and values for fractional water content, may modify this model with a greater 
component of VE and less cerebral toxicity. 
CHAPTER 1 
PATHOLOGICAL BRAIN STATES AND CONVECTION-ENHANCED 
DELIVERY 
For a variety of pathological brain states, such as traumatic brain injury (TBI), 
ischemic stroke and tumors, systemic delivery of therapeutic agents to the brain is a 
problem due to the blood-brain barrier (BBB).' Techniques such as convection-enhanced 
delivery (CED) can by-pass the BBB, however the above conditions involve a significant 
element of edema formation2 that can affect accurate dosing via C E D . ~  
TBI, stroke and tumors generally have two types of edema associated with them: 
cytotoxic edema (CE) and vasogenic edema (vE).~-' CE develops when cells of the brain 
lack an energy supply and suffer from a breakdown of ion-transport. The increased levels 
of intracellular sodium lead to increased water content and subsequent cellular s ~ e l l i n ~ . ~ ' ' ~  
The intracellular swelling causes the extracellular space (ECS) to contract when compared 
to normal brain. VE develops as a result of BBB breakdown and a build-up of water in the 
ECS, and can be characterized by ECS expansion. Diagrams outlining the ECS changes 
in both VE and CE are shown in Figure 1-1. 
Figure 1-1. Diagram illustrating extracellular space morphology under conditions of 
vasogenic and cytotoxic edema. A: Normal brain tissue. B: Vasogenic edema exhibits 
extracellular space expansion. C: Cytotoxic edema is characterized by shrinkage of the 
extracellular space. The intracellular spaces are shaded for clarity. (Diagrams courtesy of 
P. ~ a a r ~ )  
Normal Vasogenic Edema Cytotoxic Edema 
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Studies have found that TBI has an acute VE development, with .the BBB opening and 
closing within 30 minutes of injury.' Increased apparent diffusion coefficient (ADC) 
values obtained from magnetic resonance imaging (MRI) are sensitive to water protons in 
the ECS. Elevated ADC values, consistent with VE, were found up to a period of 45 
minutes post-injury in rats, however these values fell to below normal values and remained 
low for weeks afterward, consistent with predominantly CE in this phase after 
Therefore, the e d e ~ a  seen in TBI is mostly CE in nature. In ischemic brain injury, there is 
acute CE developnlent from cellular damage followed by some mixture of VE 
development several hours post-injury.6;'2 Tumors generally exhibit a high degree of VE in 
the peritumoral t i s ~ u e . ~  Some CE may be present due to ischemic anoxia in rapidly 
growing tumors where vasculature does not keep up with the  cell^.'^"^ specific 
mechanisms behind VE formation will be discussed in the next chapter. 
A common and devastating form of brain tumor is glioblastoma multiforme 
(GBM), which accounts for 50% of adult gliomas.'5 GBM is classified by the World 
Health Organization (WHO) as a grade IV astrocytoma,I6 and is seen in 9,000 U.S. cases 
annually with an incidence of 3 per 100,000 per year.'5 The highest incidence of GBM 
occurs in the elderly and white males.17 Even with the combination of surgery, 
chemotherapy, and radiation, the average survival time for patients is less than 2 years.'8 
GBM is seen in two forms: (1) a primary form which develops directly from glial 
cells, and (2) a secondary form which is thought to develop form from low-grade 
astrocytomas that are already present in tissue.17 The primary form is more aggressive and 
invasive and is seen in an older population of individuals (median age = 62.2 years), while 
the secondary form tends to arise in relatively younger patients (median age = 44.9 
years).16'19 Regardless of pathway, the clinical signs of GBM remain the same: rapid 
proliferation, diffuse invasion, angiogenesis, and tissue necrosis.16 Surrounding the tissue 
is a region of peritumoral edema (PTE) which is VE in nature due to disruption of the BBB 
in surrounding vasculature, and results in widening of the ECS, the mechanism of 
which is discussed in a later chapter. GBM cannot be cured by surgery but surgical 
removal is the primary goal with such a high grade tumor, which is then followed by a 
combination of radiotherapy and chemotherapy.15 
Chemotherapeutic treatment of brain tumors is challenging via normal vascular 
drug delivery due to the BBB.~' The normal BBB functions by preventing passage of water 
soluble drugs that have a molecular weight greater than 180, whereas most 
chemotherapeutic agents that are currently being used have a molecular weight between 
200 and 1200.~' Lipid solubility, charge, and molecular mass are the most important 
factors that determine if a drug can cross the BBB.~' By circumventing the BBB, CED is 
an effective approach to targeted delivery of chemotherapeutic agents. 1 ;22;23 CED involves 
a catheter being placed directly into parenchymal tissue and the desired therapeutic agent is 
slowly infused into the region via a pump mechanism (Figure 1-2 A). CED of toxins has 
been used to treat gliomas.15;24 1n addition, CED of chemotherapeutics such as ~ a x o l ~ ~  and 
liposomes' has been used. 
CED should not be confused with direct stereotactic inoculation. The latter 
technique creates a limited volume of distribution in the brain tissue (Vt) and therefore 
reduces the agent's therapeutic utility.21 The V, of the drug can be increased via fluid 
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convection under a constant pressure gradient.2''26 Thus, the drug distribution relies on 
the bulk flow of the fluid within the ECS of the brain. Bobo et al. found that by using a 
bulk-flow technique, they could infuse ['"c] sucrose (M,, 359) and ll'ln-labeled transferrin 
(M,, 80,000) into the internal capsule of cats under low but constant pressure.27 They 
demonstrated a linear increase in Vt that correlated with volume of infusion. CED is 
promising for clinical use, and can help circumvent the problem of poor drug delivery 
when studying other chemotherapeutic agents derived from growth factors, genetic vectors, 
enzymes, neurotrophic factors, and a n t i b ~ d i e s . ~ ~  In addition to agents mentioned above, 
28-30 CED has been used to deliver antisense oligonucleotides. CED is also applicable in 
treating Parkinson's disease and other diseases associated with local or regional brain 
abnormalities. 1 ;21:22:3 1 
Since agents delivered to the brain via CED will distribute through the ECS, 
pathological states affecting the ECS will directly affect drug distribution. As mentioned 
above, peritumoral tissue exhibits VE and some CE. '~ '~ '  Therefore, understanding CED 
distribution under pathological condition of VE is vital for accurate drug dosing and 
delivery. The behavior of infusate under conditions of CE has been well characterized in 
studies conducted by Haar, however the same studies showed inconclusive results for CED 
in a model of VE utilizing prior direct intraparenchymal infusion of a l b ~ m i n . ~  
VE leads to an expansion of ECS and an increase in the volume fraction. As noted 
in studies conducted by Haar, this condition would lead to an increase in the amount of 
available space for the infused medication to occupy.3 Therefore, it will be likely that when 
equal volumes of infusate are applied to a normal brain and one suffering from VE, the 
edematous brain tissue exhibits lower tissue distribution volume and higher tissue 
concentration of infusate (Figure 1-2 B ) . ~  
The intracellular swelling seen in CE causes a reduction in ECS and decrease in 
volume fraction. Haar expected that the Gd-DTPA infusate would expand to a higher 
tissue volume with lower tissue concentration given less ECS to occupy (Figure 1-2 C). 
This hypothesis was successfully proved correct via e~~er imentat ion.~ 
To investigate CED in different types of edema, Haar utilized rat brains to model 
conditions of VE via direct interparenchymal albumin infusion, and CE via the middle 
cerebral artery (MCA) occlusion model.3 Gadolinium-diethylene-triamine penta-acetic acid 
(Gd-DTPA) was used as a model therapeutic agent for CED. Haar found, as expected, CE 
led to a significantly higher volume of agent distribution with lower tissue concentrations 
of infusate when compared to normal brain tissue (Figure I - ~ c ) . ~  However, the volume of 
distribution and tissue concentration of Gd-DTPA did not change as expected in the VE 
model. In fact, the changes followed a similar pattern as seen in CE, although they were 
not significantly different from normal brain tissue and substantial variability in the data 
was noted. Haar cited the possibility that the needle used to infuse albumin 24 hours prior 
to Gd-DTPA infusion may have promoted "escape" of infusate along this track and might 
have acted as a stab wound, which could have led to CE development. 
Haar also noted a high degree of variance in the results. These were statistically 
different and attributed to either of two observed scenarios: ( I )  the infusate quickly 
diffused to a large tissue volume, or (2) a rapid retrograde flow of infusate. Haar explained 
Figure 1-2. Diagram illustrating infusion under conditions of vasogenic and cytotoxic 
edema. A: Diagram of infusion in normal brain. B: Diagram of possible infusion in brain 
tissue with vasogenic edema in which the increased extracellular space creates a smaller 
volume of infusion, thereby decreasing the tissue infusate concentration. C: Diagram 
illustrating infusion in brain tissue with cytotoxic edema in which the decreased 
extracellular space creates a larger volume of infusion and effectively decreases tissue 
infusate concentrations. (Diagrams courtesy of P. ~ a a r ~ )  
Normal Vasogenic Edema Cytotoxic Edema 
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the latter scenario as possibly due to back flow up a fluid channel around the cannula tract 
so that it collected in the corpus cal lo~um.~ Haar's results suggest that VE can cause either 
increased interstitial pressure in the ECS thereby forcing the infusate back up the cannula 
tract, or existing edematous conditions weakens the seal between the infusion cannula and 
surrounding tissue to allow ba~kflow.~ 
The VE model utilized in Haar's experiment presented some limitations that may 
have confounded the inconclusive results. These limitations were stated by the author as 
the small brain size, crossing of both albumin and Gd-DTPA infusion tracts and proximity 
of the infusion cannula to white matter. Due to these limitations and the invasive nature 
of the model, albumin infusion presents itself as an impractical and incompatible model for 
studying CED in the rat brain. Therefore, a better model of VE is needed in order to study 
CED in VE. The goal of the present study was to analyze an alternative model of VE in 
rodent brain that would be less intrusive and provide a consistent region of edema 
development in order to study its effects on CED. 
CHAPTER 2 
VASOGENIC EDEMA AND THE BLOOD-BRAIN BARRIER 
Pathological brain states such as traumatic brain injury (TBI), stroke, and tumors 
can produce different types of brain edema.' CE results from hypoxic conditions in 
ischemic areas of the brain. Specifically, a breakdown in ion transport across the cell 
membranes leads to a build-up of ions within the cells. As water migrates into the 
intracellular environment, there is a marked degree of astrocytic and neuronal swelling. 32-34 
Under conditions of CE, the cells swell as water accumulates inside of them. This 
expansion of intracellular space can lead to a subsequent 75% contraction of ECS." '~~ This 
change in ECS is depicted schematically in Figure 1-1 C. 
VE is commonly found in patients who suffer from intracranial tumors, severe head 
injury, cerebral ischemia, hemorrhagic stroke and CNS infectiom2 These conditions can 
lead to a breakdown in the BBB thereby increasing the permeability of local microvessels. 
The BBB protects the brain and maintains homeostasis in the brain. Disruption of the BBB 
results in a leakage of serum components into the parenchyma. This plasma leakage is due 
to the inherent pressure gradient between the vascular space and ECS .~  The protein-rich 
fluid spreads by bulk flow and by accumulating into the extracellular compartment of the 
brain, can lead to cerebral swelling, compression and displacement of the brain stem, 
increased intracranial pressure (ICP), systemic hypertension and cardio respiratory 
2;37.38 collapse. The presence of serum water and oncotically active serum proteins results in 
an expansion of the ECS. The ECS expansion has been demonstrated to lead to a volume 
fraction increase from 0.19 in normal brain to 0 . 3 0 . ~ ~  The change in ECS is depicted 
schematically in Figure 1-1 B. 
The leaky nature of microvasculature found near tumors may be mainly attributed 
to abnormalities in tight junctions found between cerebral endothelial cells. Tight junctions 
are important in maintaining BBB integrity and therefore a disturbance to their structure 
could lead to conditions of VE. Studies suggest that tumors lead to a deregulation of 
proteins associated with maintaining the BBB. Liebner et al. found a loss of claudin-1 
expression in the microvasculature in glioblastoma multiforme and a significant down- 
regulation of the claudin-5 and occludin tight junctional proteins.39 Another study also 
found abnormal expression in occludin associated with tumors.40 
As stated earlier, BBB integrity is necessary for keeping homeostasis in the brain. 
In order to study models of VE, it is crucial to understand BBB morphology and how it can 
be disrupted. These topics are discussed below. 
The Blood-Brain Barrier 
The brain is separated from systemic circulation by the BBB, which has both a 
protective and a regulatory role. The BBB is formed by the tight junctions of the 
endothelial cells that line blood vessels and the astrocytic end feet which surround them.41 
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Astrocytic end feet processes ensheath the microvasculature of the brain and help maintain 
the BBB by providing protection against hypoxia and aglycemia." Figure 2-1 illustrates 
differences between capillaries in the brain versus systemic capillaries. Unlike systemic 
capillaries, those in the brain lack fenestra, intercellular clefts, and pinocytic vesicles. 8:41 
Furthermore, cerebral endothelial cells contain more mitochondria than non-cerebral 
endothelial cells, roughly 3-5 times as much,8 which are needed by the multiple energy- 
dependent transporters in the BBB. In addition to the anatomical barrier created by tight 
junctions, studies using iron oxide nanoparticle delivery across the BBB have suggested a 
barrier at the level of the basal lamina. 21 
The BBB maintains homeostasis by selectively transporting nutrients into the brain 
via several transport mechanisms and structures, including endocytosis, paracellular 
diffusion, transcellular diffusion, cation channels, ion antiports, and ion symports."' 
Receptor mediated endocytosis plays an important role in transporting important molecules 
such as iron and insulin, while 02, C02  and lipophilic substances are transported via 
transcellular diffusion." Generally, lipid solubility is the most important factor for a 
compound to cross the BBB.~  
The major component of the BBB is the tight junction structure between vascular 
endothelial cells. The junctional complex between endothelial cells is comprised of tight 
and adherens junctions; tight junctions being the most apical element." Tight junctions are 
crucial in maintaining the BBB by limiting the paracellular diffusion of molecules and 
inhibiting build up of extracellular f l ~ i d . ~ '  Located in the cholesterol-rich region of the 
Figure 2-1: Diagram illustrating differences between cerebral and systemic capillaries. A: 
Cerebral capillary endothelial cells are sealed together by tight junctions and are 
surrounded by glial foot processes; this structure forms the blood-brain barrier. B: 
Systemic capillaries have pinocytic vesicles, fenestrations and intercellular clefts, which 
are not seen in cerebral capillaries. They also exhibit a lower number of mitochondria than 
cerebral endothelial cells. (Sketch based on diagram by Engelhard and ~ r o o t h u i s ~ ~ )  
Intercellular 
Cleft 
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plasma membrane, they are comprised of three integral proteins: (1) claudin, which creates 
the backbone of tight junctions, forniing the primary seal, (2) occludin, which confers 
increased electrical resistance and decreased paracellular permeability, and (3) junctional 
adhesion molecules (JAMS) which help regulate leukocyte migration across the BBB.~' In 
addition, several accessory proteins are found within tight junctions and provide structural 
support. These include zona occludens proteins (ZOl,Z02,Z03),  AF6,7H6 and 
cingulin."' These transmembrane and cytoplasmic proteins are linked to the actin-based 
cytoskeleton of the endothelial cells. Actin binds to ZO proteins and studies have shown 
that actin structural organization can determine tight junction integrity. Substances such as 
cytokiiies, cytochalasin D and phalloidin can disrupt actin and have been shown to also 
disrupt tight junction structure and f~nction."'~' 
The assembly and disassembly of tight junctions are controlled by intricate 
signaling cascades involving several cytoplasmic signaling proteins.41 Extracellular levels 
of calcium (ca2+) have been found to play an important role in determining tight junction 
structure. ca2+ is believed to be involved with the initial events of junctional complex 
formation:' while studies have found that if ca2+ is removed from the extracellular 
environment, electrical resistance across the membrane is reduced with a concurrent 
increase in permeability.46 
The phosphorylation of transmembrane and accessory proteins has been found to 
be important in regulating tight junction structure. Studies indicate that tyrosine 
phosphorylation can correlate to decreased occludin expression and increased permeability 
across the endothelial cells.47 As discussed before, the deregulation of these tight 
junctional proteins may play a role in forming the tumor related VE. 
Tight junction structure is also regulated by endogenous growth factors and 
cytokines. Cytokines have been found to increase leukocyte migration," which triggers a 
signal transduction cascade that can lead to junctional disorganization via breakdown of 
ZOl and occludin, resulting in blood-brain barrier di~ru~tion.~"tudies have shown that 
vasoactive cytokines like TNFa, interleukin 1 P, interferon y and histamine, in addition to 
vascular endothelial growth factor (VEGF) can increase membrane permeability. 4930 
VEGF is overexpressed in brain tumors, especially in GBM,' and is therefore another 
mechanism which can lead to conditions promoting VE. 
Blood-Brain Barrier Disruption and Clinical Applications 
Although protecting the brain from harmful toxins that may appear in systemic 
circulation, the BBB does pose a hurdle for delivery of drugs to help pathological brain 
states. As discussed above, systemically delivered drugs must overcome issues of 
appropriate size, lipid solubility and charge in order to cross into the brain." In fact, the 
BBB blocks delivery of over 98% of all drugs.jl 
In order to enhance drug delivery to the brain, techniques in disrupting the BBB 
have been explored. Research has shown that bradykinin (BK) can specifically open the 
brain-tumor-barriers through a mechanism which is mediated through the B2 receptor on 
the endothelial c e l~ s .~ '  This leads to a transient increase in intracellular ca2+ levels, which 
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increases nitric oxide synthase (NOS) that results in an increase in the permeability of the 
microvasculature in brain tumors. 21 The increase in intracellular ca2+ can alter 
cytoskeletal proteins such as nonmuscle filamin that may also enhance vascular 
2 1 permeability. Understanding this receptor mechanism has led to utilizing a BK analog, 
RMP-7 (Cereport) clinically as a means of delivering chemotherapeutic agents to brain 
5 1 tumors. 
Intra-arterial infusion of mannitol is known for its ability to temporarily open the 
B B B ~ ~ ; ~ ~  and therefore has been studied as a mechanism for delivery of therapeutic agents 
to the and understanding BBB physiology.54 other hypertonic solutions have 
been used to provide a similar BBB disruption, such as arabinose and saline; however, 
1 . lM (20%)-1.4M (25%) mannitol is -the most commonly used in preclinical and clinical 
studies, and the most carefully evaluated and proven reversible BBB disruption m e t h ~ d . ~ '  
Antineoplastic agents such as methotrexate (MTX) can be harmful in high doses delivered 
systemically. Hyperosmotic substances such as mannitol are beneficial by increasing 
delivery of substances like MTX, without the need of increasing the overall systemic 
dose.j6 In fact, studies have shown that when chemotherapy is administered along with 
osmotic opening of the BBB, there is up to a 100-fold increase in drug delivery.21 
In animal studies analyzing BBB disruption, Evan's Blue (EB) dye is the most 
commonly used agent to indicate osmotic barrier opening. A 2% EB solution is infused 
intravenously where it tightly binds to albumin. When the dye binds to albumin, the 
resulting molecule has a molecular weight of 68,500 and therefore does not cross a normal 
BBB.~' EB dye can cross over the disrupted BBB in this bound state to mark extravasated 
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albumin in parenchymal brain tissue, thereby acting as a qualitative indicator of BBB 
disruption. 5457  
The current study relies on BBB disruption to create conditions of VE. As 
discussed briefly above and thoroughly in the next chapter, hyperosmotic mannitol has 
been well characterized as a BBB disrupting agent and has also been used to create VE. 
We will examine methods of edema study and various models of VE in the next chapter. 
CHAPTER 3 
METHODS AND MODELS OF EDEMA STUDY 
There are several methods for quantifying the level of edema in brain tissue. Two 
classical techniques are wet weightldry and gravimetric analysis.60-63 These 
techniques are discussed below. 
Wet WeightIDw Weight: In this technique, the brain tissue is extracted and 
dissected in a wet or humid chamber, which ensures preservation of brain water.64   rain 
areas of interest and similar size are excised from the edematous and contralateral 
symmetrical gray matter.6s The brain samples are then weighed to obtain a wet weight and 
then dried to a constant weight at 9 0 - 1 0 0 ~ ~ . ~ " ~ ~  The dry weight is then determined. The 
percentage of water content is calculated with the following formula: % Water= (1 -dry 
wt/wet wt) x 
Gravimetric: In this technique, the brain is removed and coronal sections are cut. 
Tissue samples from the desired edematous region are dissected into pieces 1-mm3 in 
size.67-69 Multiple samples from a desired region are removed and placed in kerosene. A 
layered kerosene-bromobenzene continuous gradient column is utilized for identifying the 
specific gravity (SPGR) of each sample, and is calibrated with &SO4 samples of known 
specific gravity. Each sample is placed into the top of the column and allowed to sink and 
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equilibrate for a period of 1-2  minute^.^^.^' The equilibrium position of the sample within 
the column is used to obtain the specific gravity of the wet tissue. These values can be 
averaged over the samples from a brain region of interest and converted to water content.72 
Specific gravity (SPGR) can be converted to grams of water per gram of tissue with an 
established equation for rat brain The following is an example of a formula for cortical 
matter in the rat brain: % H20/g tissue = (462.6lSPGR) - 362.6.73 As studied by Fujiwara et 
al., the specific gravity in gravimetric analysis can be affected by the following four 
factors: ( I )  the purity of monobroniobenzene (MBB) and kerosene (K) and, (2) the 
temperature (3) duration of interaction of MBB with tissue and/or standard solutions, and 
(4) the size of tissue samples.74 
Gravimetric and wetldry weight analyses are very invasive procedures that require 
time and care for thorough and accurate analysis. Considering the steps these procedures 
involve, there is always the possibility of some inaccuracies due to water loss in the brain 
between extraction, slicing and edema measurements. The use of MRI is a non-invasive in 
method that provides a high sensitivity of relaxation times of water content changes.75 
Therefore, MRI is a useful tool for in vivo brain edema analysis76;77 The current study will 
track and analyze edema development by utilizing several MRI modalities: T2 imaging, 
water maps, and ADC maps. 
T2-weighted imaging is useful for identifying brain edema, due to its sensitivity to 
increase in water content in the brain, and has been utilized in many edema s t ~ d i e s . ~ ~ ; ~ '  
The dynamic structure and amount of brain tissue water directly influences T2 relaxation 
79 times. T2-weighted images provide a qualitative assessment of increased water content, 
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which appears as hyperintense regions in the image." MRI can also be used for obtaining 
quantitative data by way of ADC and water map analysis. 
Water Maps: Water maps provide a quantitative assessment of the brain tissue water 
content, or water fraction (f,). These water maps are generated from T1 maps, where 
relaxation times are sensitive to changes in water ~on ten t .~ '  Fatouros, et al. first developed 
an accurate in vivo model for f, assessment based on a fast exchange two-state model, 
which was validated by phantom and animal brain edema models, and later verified with 
human cLFree" bulk water in the brain exhibits long relaxation time, while 
restricted ("bound") water, which is hydrogen-bonded to macromolecules in hydration 
layers, has shorter relaxation times.83 The longitudinal T1 relaxation time is a weighted 
average between the "free" and "bound" water.84 TO acquire a pure T1 image, sequential 
inversion recovery images are processed, and then the T1 map points are converted to 
water fraction  value^.'^ These values appear in a water map that can be analyzed by 
computer software in which regions of interest (ROI) can be evaluated. Normal human 
brain water was measured to range from 68% to 80% depending on the tissue type and 
region.86 Brain water analysis via this technique has correlated well with the gravimetric 
results ( ~ ~ = 0 . 9 7 6 ) , ' ~  thereby validating this as an accurate and non-invasive technique. 
Both T2 weighted imaging and water fraction analysis provide techniques for 
identifying and measuring edema in the brain, respectively. However, for the purposes of 
the current study, it is vital to be able to characterize the type of edema that is present. One 
proven technique for this is ADC map analysis. 
ADC Maps: ADC maps are processed from a series of diffusion-weighted images (DWI) 
acquired at varying magnetic  field^.^ This imaging is sensitive to the diffusion of brain 
water.88 ADC values represent a quantification of water movement that can be affected by 
many factors such as passive Brownian thermal diffusion, active transport, and bulk 
movement.g9 Water can be restricted by cell membranesg0 and macromolecular binding.g' 
Thus, water in both ECS and intracellular space (ICS) is subject to different types of, and 
barriers to, motion.92 Faster diffusing water found in the ECS would provide higher ADC 
values, and therefore VE is characterized by an increase in ADC  value^.^ However, ADC 
values decrease in conditions of CE, due to increased ICS water, which is less mobile, due 
to interaction with intracellular macromolcules.g Using a MCA occlusion model for CE, 
Ito et al., demonstrated an ADC decrease in the rat brain from baseline of 0.6 x 10" 
mm2/sec to near 0.4 x ~n rn~ / s ec .~  Using a direct infusion model of VE, ADC values 
climbed to above 1.4 mm2/sec within an hour after cessation of in fu~ion .~  Examining 
changes in ADC values in conjunction with T2 images provides a useful technique for 
evaluating the presence of VE or CE. Studies have used this to verify the presence of 
particular edema type in humans, with VE being indicated by elevated ADC and 
hyperintense T2 changes.93 
The aforementioned MRI modalities will be utilized in the assessment of our VE 
model's characteristics and applicability to CED study. In order to select a model of VE, 
published models of VE were examined for their applicability for rat brain-based CED 
studies. A review of these models is presented next. 
Models of Vasogenic Edema 
Various animal models of VE have been used by researchers, such as albumin 
injection 94, c ~ l d - i n j u r ~ ~ " ~ ~ ,  and unsaturated fatty acid en~u l s i on ,~~  and intra-arterial 
mannitol infusion.j5 Below is a survey of some of these models and their applicability to 
the current study. Some techniques discussed below were introduced in the previous 
chapter's discussion of BBB disruption. The current study was in need of a rat-based 
model that would demonstrate repeatable conditions of VE in brain regions applicable for 
Gd-DTPA infusion and homogenous distribution such as deep gray striatum or cortical 
gray region of the forebrain. 
Infusion VE Model 
While a number of models of this type of ECS alteration have been developed, one 
of the simplest and most reliable is the infusion of a solution of normal saline containing 
98-1 02 serum albumin. This infusion model involves intraparenchynial infusion of albumin 
mixed with mock CSF via a stereotactically placed cannula into the area of interest such as 
white matter or striatum.lo3 This results in expansion of the ECS in a manner analogous to 
that seen in human brain,'04 which reaches a maximum over approximately 24 hours, and 
can persist for multiple days before The infusion edema model for VE 
shows increased water diffusion in the ECS as evidenced by hyperintense regions on ADC 
maps; Ito et al. demonstrated that ADC values increase within an hour of in fu~ion .~  
Studies conducted by Haar et al. utilized this model to investigate CED under 
conditions of V E . ~  His study involved direct infusion of albumin into parenchymal tissue 
along a tract made lmm anterior to the subsequent site for the infusion cannula tract. Gd- 
DTPA was utilized as a model therapeutic agent for CED.~  As mentioned in the first 
chapter, these studies proved inconclusive for studying VE in the rat brain. Reasons for 
this were listed as primarily due to the invasive nature of the model possibly creating some 
CE, the small size of the brain and additional factors such as tissue impedance, pore fluid 
pressure and the interactions between the tissue and   an nu la.^ The small size of the rat 
brain meant that the Gd-DTPA cannula tract was close in proximity to the albumin 
infusion tract and white matter, thereby potentially affecting the results. Since the current 
study is to be conducted in the rat brain, the model for VE should be as minimally invasive 
as possible with respect to the brain parenchyma, in order to study CED in tissue that has 
not been altered in any way, apart from the edema itself. To avoid the experimental 
limitations observed by Haar, the albumin infusion model was abandoned and other VE 
models were explored for CED study. 
Unsaturated Fatty Acid Model 
The unsaturated fatty acid emulsion model is a novel technique which has produced 
VE in the cat brain.97 The fat emulsion was made via a mixture of linoleic acid or oleic 
acid with saline. The fat globules formed were less than 2 times the size of red blood 
cells.97 This emulsion was infused cephalad into the internal carotid artery for 5 minutes at 
a rate of 4 m ~ l m i n . ~ ~  This model may have some potential when used for research with 
BBB disruption. MRI studies revealed VE and reversible changes after the unsaturated 
fatty acid emulsion was infused into the carotid artery. Specifically, diffusion-weighted 
imaging (DWI) and subsequent ADC maps showed evidence of VE 1 hour after emulsion 
infusion and no sign of cytotoxic effect.97 Although this may be useful, no studies are 
available to prove the effectiveness of this technique in the rat brain, nor have consistent 
areas of large edematous regions in the gray matter been demonstrated. 
Toxin-induced Model 
Another method of inducing conditions of VE in the rat is intraperitoneal injection 
of a toxin. One study has explored this model using Hooded Wistar rats injected with the 
Clostridium Perfringens (CI P) type D epsilon toxin which preferentially binds to the 
brain.'07 Although the mechanism that causes the VE to form is unknown, the authors used 
immunocytochemistry to detect the presence of endogenous albumin.lo7 They found 
albumin in the walls of the cerebral microvessels as soon as 1 hour post injection, with 
maximal leakage of albumin into the parenchyma occurring at 24 and 48 hours.lo7 The 
authors found a partial reduction in expression of endothelial barrier antigen (EBA) that 
was most prominent at 24 and 48 hours post-injection of the toxin.lo7 EBA is a protein with 
barrier function and is specifically expressed by rat CNS endothelial cells. 
Immunostaining for EBA can also be used to detect BBB disruption. lo' Although this 
toxin-based model seems to produce VE conditions, the breadth of such edema 
development has not been characterized or shown to be repeatable in specific regions of 
the rat brain. 
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Another toxin model for VE has been produced in piglets using an intrathecal 
injection of bacterial lipopolysaccharide (LPS)."~ Clinical conditions such as bacterial 
meningitis and traumatic brain injury show an increase in BBB permeability that is 
mediated by inflammatory reaction. LPS from E. coli was used to mimic such 
inflammatory conditions to produce VE. The LPS was injected into the cisterna magna 
while the intracranial pressure (ICP) and cerebral blood flow (CBF) were measured, along 
with intracerebral microdialysis to analyze interstitial levels of glucose, pyruvate, lactate, 
glutamate, glycerol and urea.''' The authors found that 4-7 hours post LPS injection, ICP 
increased and reached a plateau, and CBF increased by 46%. The LPS caused a 
statistically significant decrease in glucose and increase in lactatelpyruvate ratio. There 
was no increase in glycerol, leading the authors to conclude that there were no biochemical 
signs of cell membrane degradation or tissue damage. This model, however, has not been 
tested or characterized in the rat brain, like the unsaturated fatty acid model discussed 
previously. 
Cold Injury Model 
Another widely used model for VE is the cold-lesion or cold-injury rn~de l . ' ' ~  This 
is conimonly created by application of a cooled metal probe to either an intact cranium or 
dura. The metal probe can range from al~rninum'~' to copper111 and is cooled to 
112 temperatures around -80°C in a mixture of dry ice and methyl butane, or liquid 
nitrogen.'13 It is then placed onto the dura mater over the left parietal cortex for 30 seconds 
through a 5-mm-wide ~raniotorny."~ 
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The cold-injury produces a necrotic lesion mainly confined to the cortical gray 
matter surrounded by a narrow zone of increased permeability.1 '"RI studies of the cold 
injury model have shown a periphery region of VE surrounding the area of in~u1t. l '~   he 
resulting edema does not form from the lesion area itself since the vessels in the lesion area 
are rapidly occluded by intravascular thrombosi~."~ The likely method of extravasation in 
the area below the lesion is pinocytic activity as suggested by Baker et al.'18 Another study 
mentions that removal of necrotic tissue will prevent formation of edema, thus suggesting 
that a substance released from the necrotic tissue is a stimulus for pinocytosis. As edema 
fluid spreads from this region, it moves into adjacent white matter via bulk 
After cold-injury, cortical necrosis peaks after 24 hours,'20 with maximal BBB 
disruption 24 hours after injury.l2l The delayed build-up of edema is attributed to oxygen 
free radicals, as seen in cortical brain injury and traumatic brain injury.lZ2 During this time, 
the volume of the lesion can expand up to 400%, which can be attributed to the progressive 
death of parenchymal tissue and is an important manifestation of secondary brain damage. 
This injury is ftlrther complicated by development of VE. One study has shown that the 
freeze injury induced brain edema can decrease the microcirculatory blood flow up to 50% 
from baseline. This results from the narrowing of the capillaries due to compression by 
swollen astrocytic processes.123 The posttraumatic hemispheric swelling reaches 50% of its 
maximum at 1 hour and maximum at 12 hours. 
A wet-dry weight analysis of the brains post cold-injury showed a peak water value 
of 79.87% after 2 hours, which then gradually decreased and fell after 32 hours to below 
.the control value of 78.22 f 0.47%.lZ4 ~ x c e s s  protein content in the injured hemisphere 
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peaked at a value of 21.545-2.76 mglg dry weight after 8 hours. The uninjured hemisphere 
was considered to have a negligible level of protein extravasation, which was by definition, 
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zero. 
The cold-injury model can produce conditions of VE in a peripheral region of 
injury,'26 but is not applicable for CED studies due to the shape and cortical localization of 
the edema. The region of edema does not penetrate into the deeper gray matter of the brain 
nor does it create an expansive volume of edema that can be used for studying Gd-DTPA 
CED. The current study required the brain volume of edema to be more widespread and 
larger than the planned infusate distribution. Creating a widespread region of edema 
within a hemisphere is important for studying how the infusate will behave under 
conditions of VE. It was also necessary to have conditions of parenchymal space 
enlargement as seen in VE and not a combination of other injury as seen in cold-injury.'27 
The perturbation itself may alter the tissue in an unpredictable or irreproducible manner, in 
addition to the associated brain necrosis that may complicate the infusion studies. For these 
reasons, the cold-injury model was not selected for the current study. 
Mannitol Model 
Studies have found that intracarotid injection of 25% (1.4M) mannitol can create 
reversible opening of the BBB by inducing cerebrovascular dilation and osmotic cell 
shrinkage of endothelial cells. This allows for the widening of the interendothelial tight 
junctions to an estimated radius of 200A. 21;53;128 At the subcellular level, there may be 
second messenger systems (e.g. calcium influx and nitric oxide) effected by osmotic stress 
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along with cytoskeletal changes, all contributing to the barrier opening." Studies have 
shown that this opening is reversible, with vascular permeability returned to baseline 
within 24 * 14.3 minutes.21 
As mentioned in previous chapters, intra-arterial infusion of mannitol is utilized in 
the clinical setting to open the BBB for drug de1 i~e ry . l~~  Mannitol is also clinically 
administered via intravenous (IV) infusion in order to lower intracranial pressure (ICP) 
after development of edema. 130-133 IV delivery of mannitol can reduce ICP by acutely 
lowering blood viscosity and increasing cerebral blood flow, which triggers cerebral 
arterioles to undergo autoregulatory vasoconstriction.'34 a his autoregulatory mechanism 
directly affects cerebral blood flow, thus controlling the volume of intracranial blood and 
thereby lowering the 1 ~ p . l ~ ~  
Animal researchers deliver mannitol to the brain by way of internal carotid artery 
(ICA) utilizing two different catheterization techniques. Some experiments have involved 
retrograde catheterization of the external carotid artery (ECA) with SP- 10 tubing to the 
bifurcation of ECA and ICA with ligation of the pterygopalatine artery (PTA). 57;95;136-138 
Other studies directly catheterize via the common carotid artery using PE-50 tubing while 
57;139 ligating the proximal end of the external carotid and pterygopalatine arteries. Animal 
subjects are anesthetized via isoflurane while the degree of BBB disruption can be 
monitored by EB dye delivered via femoral vein prior to mannitol infusion.54 
Kaya et al. observed the following effects after left ICA infusion of mannitol: (1) 
cardiovascular depression during infusion leading to a drop in arterial blood pressure, 
returning to normal values within seconds of infusion, (2) water content in the left 
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hemisphere of the brain increased significantly compared to the right hemisphere within 10 
minutes of infusion, and (3) BBB permeability to albumin, as seen by EB staining, was 
significant in the left hemisphere.57 The same study found that magnesium sulfate, when 
delivered via intracarotid or intraperitonial routes, can attenuate the BBB disruption effect 
of mannit01.~~ 
A previous study has shown that for the highest amount of BBB disruption with 
reduced mortality, an optimal rate of infusion of 25% mannitol at 37OC for adult Sprague- 
Dawley rats is 0.25ml/kg/s over 30  second^.^' This rate and duration can lead to a reliable, 
reversible BBB opening without an immediate or delayed neurotoxic Studies 
have found that this concentration of mannitol has shown excellent BBB disruption in 95% 
of normal rats.21 For a 300g rat, this amounts to a flow rate of roughly 4.5 mllmin and a 
total amount of 2.25m1 of solution delivered. 
Histological rat brain studies by Salahuddin et al. have shown that after one hour, a 
single 1.5mL injection of 1.4M (25%) mannitol via the ICA can lead to spongy appearance 
in the neuropil, perivascular swelling and collapsed, dark neurons. 136,137 These pyknotic 
cells can be considered either dead or dying which will eventually be subject to 
macrophage mediated rem0va1.l~~ Further investigation using electron microscopy has 
yielded that the dark and shrunken neurons were collapsed and surrounded by swollen 
processes which were mostly astrocytic origin.137 The perivascular swelling was found to 
be due to swollen astrocytic processes as well.137 The spongy appearance in the neuropil 
was also attributed to swollen cellular processes.137 The shrunken cellular appearance was 
attributed by the authors to possible C E . ' ~ ~  However, the same study does cite VE being 
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0 b ~ e r v e d . l ~ ~  Although that study was not clear as to how VE was observed, other literature 
has listed swollen astrocytic processes and perivascular end feet as indications of VE.'~' 
Dilated spaces around capillaries have been observed in other VE studies.I4' These 
astrocytes are believed to swell due to pinocytosis of fluid from escaped ve~se1s . l~~  
As reviewed in this chapter, BBB disruption due to mannitol infusion has been 
investigated in many studies; 57;136:137;143 however, based on a database search, only one 
study actually utilized mannitol specifically for creation VE, via multiple mannitol 
infusion in the internal carotid artery of mongrel dogs.55 
Based on the mannitol effects illustrated by Kaya et al. 57 and previous use by 
Turski et a1. ,55 it appeared that favorable conditions of VE could be achieved with 
mannitol induced BBB disruption. Of all the researched models, mannitol delivery seems 
the most applicable for infusion studies. Intra-arterial infusion of mannitol appears to have 
the possibility of creating a wide-spread area of edema in the deep and cortical gray matter, 
without any other complications (e.g. brain necrosis seen with the cold-injury model5'). 
The current study will focus on using mannitol infusion to model conditions of pure 
VE in the rat brain. Although the time course of BBB disruption has been extensively 
the characterization of edema in the rat brain induced by intraarterial delivery 
of mannitol has not been reported. The current study will characterize the time course and 
extent of edema formation in order to establish a model of VE suitable for CED studies. 
CHAPTER 4 
HYPOTHESIS AND SPECIFIC AIMS 
In order to plan effective targeted convective drug delivery into the brain, it is 
important to understand how the infusate will distribute in the pathological tissue. For 
example, chemotherapeutic treatment of brain tumors requires knowledge of how the agent 
infused via CED will distribute in brain tissue exhibiting VE seen in peritumoral regions. 
Although CED has been characterized in normal brain and conditions of CE, there has 
been little success in obtaining conclusive results under conditions of V E . ~  Previous 
studies conducted by Haar utilized direct parenchymal infusion of albumin to create a 
model of V E . ~  This model, however, proved incompatible with CED study and therefore a 
new model was needed. The purpose of the current study was to modify an existing model 
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of VE in order to create conditions of VE in a consistent and reliable fashion that will 
cover an area large enough to contain the volume of CED infusate. 
Background research on current models of VE, as reviewed in the previous chapter, 
led to the possibility of using intracarotid infusions of 25% mannitol. Utilizing the 
knowledge of previous studies that employed mannitol for BBB disruption and VE 
production, the current study tested different doses of mannitol to achieve optimal 
conditions of VE. MRI techniques and histological examination were used to verify the 
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presence of VE and characterize the time-course of edema development to determine its 
applicability for future Gd-DTPA CED studies. 
Hypothesis: Multiple intracarotid infusions of 25% mannitol will create reproducible 
conditions of pure VE in the gray matter of a single hemisphere in the rat brain. The tissue 
volume affected by VE will be larger than a planned model therapeutic CED infusate 
volume and the time course of VE long enough for infusate to distrib~~te and be measured. 
Specific Aims: 
1) To use multiple inhsions of mannitol to obtain reproducible and unilateral edema 
for CED study in the gray matter of the rat brain. 
2) To characterize the time course of edema development. 
3) To verify presence of VE with T2 imaging, ADC value analysis, water maps and 
histological analysis. 
CHAPTER 5 
METHODS 
All animal experiments were approved by the Committee for the Care and Use of 
Laboratory Animals at Virginia Commonwealth University. Male Sprague-Dawley rats 
with an average weight of 320g were anesthetized and catheterized via the right common 
carotid artery (CCA) and femoral vein. Preliminary experiments were conducted (n= 17) 
in which mannitol was infused at different rates and volumes until a consistent and 
unilateral edema was observed based on EB dye staining and T2-weighted MRI. 
From these studies, we found that 3 infusions of 25% mannitol30 minutes apart 
could possibly serve as a viable model for VE in the rat brain, which warranted further 
investigation. Rats (n=l 1) received this series of mannitol infusion and after the third 
infusion, MRI was conducted 30 minutes, 1 hour, 24 hours and 48 hours later. Control rats 
(n=9) were left untreated and scanned. Sham operated animals (n=4) were operated and 
scanned at 1 hour (n=2) and 48 hours (n=2). For histological studies, 3 rats with 3 
infusions of mannitol were sacrificed 2 hours after the last infusion. Further rats were 
processed for control (n=2), which were left untreated, and sham-operated animals 
sacrificed 2 hours (n=l), and 48 hours (n=l) after CCA ligation. Details for the procedures, 
imaging, histological processing and data analysis are discussed below. 
Mannitol Infusion Model 
CCA Catheterization: (Figure 5-1 A) Rats were anesthetized with 1.5% isoflurane in a 2: 1 
mixture of nitrous oxide and oxygen, and rectal temperature was maintained at 37OC using 
a heat pad. Through a midline neck incision, the right CCA was exposed along with the 
internal carotid artery (ICA) and external carotid artery (ECA) branches. The occipital 
artery was cauterized and dissected to expose the ICA branch. A 4-0 suture was used to 
ligate the ECA, while a 6-0 suture was used to ligate the pterygopalatine artery (PTA) 
branch of the ICA. This ligating of arterial branches ensured mannitol infusion would only 
occur along the ICA into the right hemisphere of the brain. The CCA was ligated at the 
proximal end and a P-50 catheter was introduced into the lumen and inserted up through 
the ICA origin. The catheter was secured by tightening another 4-0 suture around the 
catheterized CCA. The femoral vein was also catheterized in a similar fashion with a P-50 
catheter, after ligating the distal end with a 4-0 suture. 
Femoral Vein Catheterization: (Figure 5-1 B) The right femoral vein was exposed and 
ligated with a 4-0 suture at the distal end. A PE-50 catheter was inserted into the right 
femoral artery for either blood pressure monitoring (n=5), or EB dye delivery (n=5). 
Figure 5-1. Diagram depicting catheterization of CCA and femoral vein. A: The CCA 
with catheter and ligated branches (the occipital artery is cauterized). B: The femoral vein 
catheterized and ligated. 
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Evan's Blue Dye: EB dye was utilized to mark BBB disruption on mannitol infused rats 
(n=5), and brains were examined 2 hours (n=3) and 48 hours (n=2) after the last mannitol 
infusion. EB dye (2% in saline) was delivered at 2mllkg via the catheterized femoral vein 
5 minutes prior to the first mannitol infusion. 
Mannitol: Mannitol(25N at 37.0+1 "C) was delivered via catheterized CCA at 2.5mllkgls 
for a period of 30 seconds. In total, 3 doses of mannitol were delivered at 30-minute 
intervals. After the third infusion, the catheters were removed. 
Imaging: Control rats (n=9) were left untreated for imaging. For surgical control, sham- 
operated rats (n=4) had their right CCA sutured closed and were imaged 1 hour (n=2) or 48 
hours later (n=2). Mannitol was infused in 11 rats. After the third mannitol infusion, rats 
were scanned to acquire T2-weighted (T2W), diffusion-weighted (DWI), and T1 Maps 
(TIM). The time interval between the infusion and imaging and rats scanned per image 
type were as follows: 30 minutes (n=3 for DWI and TIM), 1 hour (n=4 for DWI and 
TIM), 24 hours (n=2 for DWI, n=3 for T1 M) and 48 hours (n=3 for DWI, n=4 for TIM). 
Although EPI DWI imaging was used for its short acquisition time, some the same rats 
(n=5) were also imaged with SE DWI for control (n=l), after 1 hour (n=2), and after 1.5 
hours (n=3) of mannitol infusion. T2 images were acquired at every scan. Imaging 
procedures are described below. 
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Imaging placement: Each rat to be scanned was either kept under isoflurane anesthesia if 
imaging was conducted on the same day as mannitol infusion, or anesthetized by 
intraperitonial administration of 0.5 ml of ketamine (50mglml) for 24 and 48-hour follow- 
up. Each rat was placed in an acrylic imaging tube, secured via plastic ear bars, and fitted 
with a surface coil. Images were acquired with a 2.4 T, 40-cm bore magnet (Bruker 
Medical, Inc., Billerica, MA) equipped with a 12 cm inner-diameter, actively shielded 
gradient insert (maximum gradient strength: 25 Glcm). An actively decoupled RF coil set 
was used for RF excitation/reception and was con~prised of a 7 cm inner-diameter 
"birdcage" design resonator and a 2 cm diameter circular surface coil. 
T2 images: T2-weighted images with echo time (TE) of 100 msec, and repetition time 
(TR) of 3000 msec, were obtained on 7 contiguous coronal slices 2-mm thick with a 
resolution of 96 by 96. 
EPI DWI: DWI (TR: 1500 msecl TE: 4lmsec) images were taken which employed an echo 
planar based spin echo sequence appropriately modified to include diffusion-sensitizing 
gradients along the readout (horizontal) direction with a duration of 9msec and a gradient 
separation of 20 msec. Each data set consisted of 5 coronal slices of the forebrain and 
midbrain region, each slice being 2-mm thick with a resolution of 128 by 128 and a 30- 
mm2 field of view. Diffusion weighting factors, or b values of 0 and 1 042s/mm2 were used 
(maximum gradient strength of 23 Glcm). ADC maps were processed from DWI images 
using the MRVision software package (MRVision Co., Winchester, MA). 
SE DWI: DWI (TR: 1500 msecl TE: 39 msec) images were taken which employed a spin 
echo sequence appropriately modified to include diffusion-sensitizing gradients along the 
readout (horizontal) direction with a duration of 4 msec and a gradient separation of 25 
msec. Each data set consisted of 5 coronal slices of the forebrain and midbrain region, 
each slice being 2-mm thick with a resolution of 128 by 128 and a 30-mm2 field of view. 
Diffusion weighting factors, or b values of 4.2, 160.5, 557.6, and 1195.6 s/mm2 were used 
(maximum gradient strength of 23 Glcm). ADC maps were processed from DWI images 
using the MRVision software package (MRVision Co., Winchester, MA). 
T1 images: Two-dimensional T1 imaging series were generated with a spin echo, echo- 
planar imaging sequence preceded by an inversion recovery preparation period using a 
hyperbolic secant inversion pulse. T1 maps were calculated from data obtained on 4 
coronal sections at a thickness of 2.5mm and slice separation of 3.0mm. Inversion 
recovery times were: 30,60, 150,300, 700, 1300, and 2500 msec. 
Data Analysis: Average ADC values were obtained from regions-of-interest (ROI) 
outlined in the cortical and deep gray matter over four slices. Water maps were calculated 
from the T1 Maps using the MRVision software. Average water fraction (f,) values are 
extracted from ROIs defined in cortical and deep gray tissue structures over four slices. 
Figure 5-2 provides an example of left hemisphere cortical and deep gray ROI outlines 
examined on ADC and water maps, similar ROIs were used on the right hemisphere. Mean 
ADC and f, values from edematous regions for each time period were compared to 
contralateral and untreated brain means using t-tests and graphical analysis. 
Gd-DTPA infusion 
These steps were carried out to test the appearance of infusate in a selected region 
of the brain such that volume of distribution would occupy edematous tissue. Utilizing T2 
images from preliminary experiments, a tentative CED infusion sight located in the cortical 
gray of the forebrain (4 mm anterior and 3 mm right lateral to bregma). The 
macromolecular contrast agent gadolinium (Gd) chelated by diethylenetriamine pentaacetic 
acid (DTPA), (Gd-DTPA), was utilized to model therapeutic agent distribution. 
Guide cannula implantation: 2 rats received a fixed guide cannula 24 hours prior to 
imaging as follows. Each rat was anesthetized by intraperitoneal administration of 0.5 ml 
of 1 : 10 ketamine:xylazene mixture (both 50mglml) and positioned in a stereotactic frame. 
Based on preliminary mannitol studies, a location in the right frontal cortex was decided 
upon as an infusion site. An infusion burr hole was created 3 mm lateral and 4 mm anterior 
to bregma. An outer guide cannula (Plastics One, Inc.; Roanoke, VA) was stereotactically 
placed through the infusion burr hole and fixed to the skull and to a plastic anchor screw 
using methylmethacrylate. The tip of the guide cannula was capped until infusion. 
Figure 5-2. Example ROIs outlined on ADC and Water Maps. A: ROIs drawn in left 
cortical and deep gray on an ADC map. B: ROIs drawn in left cortical and deep gray on a 
water map. 
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Contrast infusion and imaging: Rats (n=2) received identical infusions of 10.833 mM Gd- 
DTPA in mock CSF. This solution was doped with O.1lmM manganese chloride to match 
the TI value of the rat caudate putamen. The rat was positioned inside an acrylic imaging 
tube, secured with plastic ear bars, and fitted with the circular surface coil (Bruker, 
Billerica, MA). An inner cannula was inserted into the infusion guide cannula, the rat and 
entire acrylic imaging tube placed in the magnet, and 10 pl of the Gd-DTPA solution was 
infused at a steady rate of 0.2 pllminute over 50 minutes, using a motor-driven syringe 
(Bioanalytical Systems, Inc., West Lafayette, IN). During and following this infusion, T1 
mapping data was acquired every 10 minutes for 130 minutes, resulting in 13 data sets. T1 
maps were calculated from data obtained on 4 coronal sections at a thickness of 2.5mm and 
slice separation of 3.0mm. Inversion recovery times were: 30, 60, 150,300, 700, 1300, and 
2500 msec. Each rat was then removed from the magnet and sacrificed. 
Histological Procedures 
Common Preparation for Light and Electron Microscopy: Untreated, sham-operated and 
mannitol-infused rats were prepared for both light (LM) and transmission electron 
microscopy (TEM). 2 hours post mannitol infusion, rats were transcardially perfused via 
catheter inserted into the left ventricle. First, 0.9% saline was delivered for 2-3 minutes 
until the returning perfusate from the right atrium appeared cleared of blood. Next, 
perfusion of fixative was initiated. Fixative was a solution of 4% paraformaldehyde and 
2% glutaraldehyde in 0.1 M Sorenson's phosphate buffer. A total of 500mL of fixative was 
perfused through the brain. The brain was extracted and sectioned into 4 coronal slices, 
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beginning from the frontal pole at the following thickness: 3mm, 2mm, 3mm, and 3mm. 
The 2mm slices were processed for TEM analysis and remaining tissue was utilized for 
LM processing. 
Light Microscopy Preparation: Each slice for LM study was embedded in paraffin blocks. 
From each block, 2 consecutive 7 pm slices were cut with a microtome. Each slice was re- 
hydrated with graded ethanol series: loo%, 9096, and 70% for two minutes each. Next they 
were stained with hematoxylin then with eosin stains. After staining, each slice was 
dehydrated with graded ethanol and 2 consecutive slices from the same block were 
mounted on the same slide with permount. Images were captured using the Nikon E800 M 
Eclipse Microscope with SpotRT camera (Diagnostic Instruments). 
Transmission Electron Microscopy Preparation: The 2-mm thick sample for EM study was 
cut via vibratonie into 3 consecutive 40 pm thick slices, with remaining tissue processed 
for LM study. Each slice from the sample was washed with O.1M Sorensen's phosphate 
buffer at 4OC then postfixed with 1% osmium tetroxide in 0.1M phosphate buffer at 4OC 
for 1 hour. Samples were then washed with buffer and dehydrated with a cold ethanol 
series: 50%, 70%, 80%, and 95%, for 5 minutes each. Next, slices were dehydrated with 
100% ethanol at 20°C, followed by 3 changes of 100% propylene oxide for 10 minutes 
each. Slices were placed in a 1 : 1 propylene oxide:PolyBed solution for 4 hours, and then 
transferred to pure PolyBed resin overnight. Each section was embedded on vinyl slides 
and placed in a 60°C oven overnight. After LM examination, sections were chosen and 
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excised from the cortical and deep gray region for remounting on blocks and further 
sectioning. Using the LKB 2 120 Ultramicrotome, 9008 sections were cut with a diamond 
knife. Each section was then placed on Formvar-coated slotted grids and stained with 
uranyl acetate and lead citrate for TEM study. A JEOL JEM-1230 (JEOL USA, Inc.) 
transmission electron microscope was used to capture images via the Ultrascan 4000 
camera (Gatan, Inc.) 
CHAPTER 5 
RESULTS 
The selected mannitol model for VE involved 3 doses of right intracarotid mannitol 
infusion at a rate of 0.25mllkglsec over 30 seconds, 30 minutes apart. This model was 
examined by qualitative and quantitative analysis of data obtained from MRI, gross and 
histological tissue examination. Gross brain observation using EB dye was conducted to 
look for evidence of BBB disruption. ' MRI was used to track development of edema over 
time using water (f,) map and ADC map analysis. T2-weighted imaging provided a 
qualitative understanding of edema development. Light microscopy (LM) and 
transmission electron microscopy (TEM) were used to examine the treatment effect on the 
tissue and support evidence of any edematous conditions discerned from MRI study. The 
results from each of these analyses are described below. 
Evan's Blue Dye 
Brains extracted from rats after mannitol delivery clearly showed unilateral EB dye 
staining in the right hemisphere. Figure 6-1 shows a representative image of the brain 
upon extraction 2 hours after the 3rd mannitol infusion. All rats that had brains perfused 
with mannitol into the right internal carotid artery (ICA) exhibited staining throughout the 
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ipsilateral hemisphere. As seen in the coronal sections, the staining permeated through the 
cortical and deep gray (caudatelputamen) matter, while the contralateral left hemisphere 
remained unstained. 
T2-Weighted Images 
The T2W images obtained 30 minutes and 1 hour after the last mannitol infusion 
displayed a consistent and marked liyperintensity through the right hemisphere, ipsilateral 
to infusion. This was a uiiilateral hyperintensity that appears to occur through all of the 
forebrain and midbrain cortical and majority of deep gray (caudatelputanien) regions. 
Swelling was also observed within the right hemisphere, marked by a midline shift. There 
was no apparent hyperintensity in the contralateral gray matter, however, the contralateral 
ventricles and white matter did show some hyperintensity. Similar results were seen in the 
T2W images 1 hour after the last mannitol infusion. Figure 6-2 A contains T2W images of 
a sham-operated and a normal untreated control rat brain, both exhibiting uniform intensity 
throughout the hemispheric gray and white matter. Figure 6-3 A and Figure 6-4 A depict 
representative T2W images of a brain after 30 minutes and 1 hour, respectively, from 
different animals. An untreated rat brain T2W image is included for comparison. Figure 
6-5 A and Figure 6-6 A respectively depict T2W images from the same rat after 24 and 48 
hours of infusion and include an untreated rat brain T2W image for comparison. T2W 
images seen after 24 hours displayed a large reduction in swelling and hyperintensity when 
compared to the previous day scans, with some remaining hyperintensity in the cortical 
gray region of the forebrain. After 48 hours, the T2W images displayed no obvious 
swelling. In addition, with the exception of some reduction in the right cortical 
hyperintensity seen 24 hours prior, the right hemisphere gray matter intensity appeared to 
match controls. 






Water Maps 
Water maps obtained 30 minutes and 1 hour after mannitol infusion displayed 
hyperintensity in the right cortical and deep gray regions, ipsilateral to mannitol perfusion. 
As shown in Figure 6-7, these regions appear to be analogous to hyperintensity observed 
in correlate T2W images obtained from the same animal 1 hour post infusion. Water maps 
obtained at later time points did not show evidence of intensity difference between the 
hemispheres. 
Water maps provided water fraction (f,) values that were extracted via region of 
interest (ROI) analysis described in the previous chapter. Figure 6-8 contains graphs that 
show changes off, values over time after mannitol infusion, for cortical, deep and average 
gray matter. Values at 0 hours represent control f, values in untreated brains. Average 
gray matter had a normal f, of 77.8% in the right hemisphere and 77.9% in the left (Figure 
6-8 A). Within 30 minutes of mannitol infusion, averaged ipsilateral gray matter (right 
hemisphere) displayed a water fraction of 83.8% versus a level of 78.3% seen in the 
contralateral gray matter (left hemisphere). There was a statistically significant difference 
observed between the hemispheres (p<0.05) which remained high after 1 hour, where f, 
was increased to 84.8% in the right hemisphere compared to 78.3% in the left, as indicated 
by the asterisks on the graph. The f, values dropped to near normal values at 24 and 48 
hours, with no significant difference existing between right and left hemispheres. 
A similar trend was observed when the cortical and deep gray regions were 
analyzed separately. Cortical gray tissue had a normal fw of 79.3% and 79.2% in the left 
and right hemispheres, respectively (Figure 6-8 B). At both 30 minutes and 1 hour, the 
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right gray matter showed a higher average than the left, which was statistically significant 
(p<0.05). The right cortical gray matter showed a rise in f, to 85.5% after 30 minutes and 
86.3% after 1 hour. The contralateral left cortical gray matter remained at normal levels 
after 30 minutes, however, increased to 8 1 .O% after 1 hour. The left cortical gray average 
at 1 hour produced a p-value of 0.048 using a t-test compared with the normal values (at 
time 0), which suggests a statistical difference (p<0.05). The left hemisphere also showed 
a difference in f, at 48 hours that was higher and statistically different from normal 
(p=0.025). Right hemispheric cortical gray f, values dropped after 24 and 48 hours. Right 
and left cortical gray f, values were not significantly different between each other after 24 
and 48 hours; however, the right cortical gray had an elevated f, at 24 hours (80.9%) that 
was statistically significant when compared to the normal right cortical value (79.2%). 
Deep gray (caudatelputamen) tissue had a normal f, of 76.3% for the left and 76.7% for 
the right hemisphere, which appeared to be less than the normal f, observed in cortical 
regions (Figure 6-8 C). The right deep gray matter showed higher f, values after 30 
minutes (82.0%) and 1 hour (83.2%) when compared to the left deep gray matter that 
remained near 77%, that were statistically different (p<0.05). The right hemisphere 
dropped to near normal at 24 (77.9%) and 48 hours (77.9%) with no statistically significant 
difference from the left hemisphere. The left hemisphere remained near normal through the 
24 and 48 hour observations with no statistically significant change from normal values as 
seen in the cortical gray. Sham-operated rats displayed normal water values at 2 hours 
and 48 hours post-surgery, with no statistically significant difference in the values between 
the hemispheres and when compared to normal brain tissue. 
Figure 6-7: Water Map image of rat brain 1 hour after the third mannitol infusion. 
A: Treated brain. Note hyperintense regions in right hemisphere. B: T2 images of 
corresponding slices from same treated brain. 
Figure 6-8: Graph of water fraction (f,) changes in gray matter after mannitol delivery. 
A: Combined cortical and deep gray matter averages over time. B: Cortical gray matter 
changes over time. C: Deep gray matter (caudatelputamen) changes over time. 
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Apparent Diffusion Coefficient Maps 
ADC maps obtained 30 minutes and 1 hour post mannitol infusion showed some 
hyperintensity in the right hemispheric cortical and deep gray regions, when compared to 
the contralateral hemisphere. There is also a hyperintensity observed in the white matter 
tracts through the corpus callosum. Figure 6-9 displays the ADC map obtained at the 1 - 
hour mark in the same animal whose water map is shown in Figure 6-8. This is a 
representative ADC map, where hyperintense regions were not as pronounced as seen in 
T2W images and water maps. 
ADC ROI analysis was conducted in a manner similar to water map analysis. 
Figure 6-10 contains three graphs corresponding to the average gray, cortical gray and 
deep gray (caudatelputamen) ADC value changes over time. Values at 0 hour represent 
control ADC values in untreated animals. Overall, the average gray matter had normal 
ADC values of 0.58 x mm2/sec in left and right hemispheres (Figure 6-10 A). After 
mannitol infusion, average gray values were 0.53 x loe3 mm2/sec in the left hemisphere 
and 0.51 x m 2 / s e c  in the right hemisphere, 30 minutes after infusion. Afier 1 hour, 
these values were 0.45 x mm2/sec in the left hemisphere, while remaining at 0.5 1 x1 o - ~  
mm2/sec in the right hemisphere. Of note, the differences between the hemispheres were 
not statistically significant at these two time points. Also, there was no statistically 
significant change in average gray matter values when compared to normal brain tissue 
from the 0 time measurements or from untreated control animals. After 24 hours, 
hemispheric average gray matter ADC was 0.54 mm2/sec in the left hemisphere and 0.64 x 
10" mm2/sec in the right hemisphere. The right hemisphere gray matter had a higher ADC 
Figure 6-9: ADC images of rat brain 1 hour after the third mannitol infbsion. Note 
hyperintense regions in right hemisphere. 
Figure 6-10. Graph of ADC changes in gray matter after mannitol delivery. A: Combined 
cortical and deep gray matter averages over time. B: Cortical gray matter changes over 
time. C: Deep gray matter (caudatelputamen) changes over time. 
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than the left after 24 hours, and this difference was statistically significant (p<0.05). When 
compared to normal tissue ADC from the 0 time measurements, each hemisphere also 
showed a statistically significant difference at the 24-hour mark. After 48 hours, the 
average gray matter ADC was near normal values with no statistically significant 
differences observed. 
When observed separately, cortical gray matter is seen to follow the same pattern as 
the average gray matter values (Figure 6-10 B). The normal cortical gray matter ADC was 
measured to be 0.59 x mm2/sec in the left hemisphere and 0.57 x lo-' mm2/sec in the 
right hemisphere. The left and right cortical gray matter ADC values were 0.56 x lo-' 
nim2/sec and 0.52 x lo-' mm2/sec, respectively, 30 minutes after mannitol infusion. After 
1 hour, the left cortical gray matter ADC value was 0.48 x lo-' mm2/sec, while the right 
cortical gray matter value was 0.53 x lo-' mm2/sec. The differences between the left and 
right cortical gray at 30 minutes and 1 hour were not statistically significant; nor were they 
individually statistically significant in difference from normal values. After 24 hours, the 
left cortical ADC value was 0.58 x 1 o - ~  mm2/sec, while the right cortical ADC was higher 
than normal at 0.67 x lo-' mm2/sec. The right cortical gray matter had a higher ADC from 
both the normal tissue and contralateral regions that was statistically significant (p<0.05). 
After 48 hours the ADC values were near normal with no statistically significant 
differences. 
The deep gray ADC values followed the same pattern of change observed in the 
cortical and overall gray matter, with some differences (Figure 6-10 C). The normal ADC 
values in the deep gray were observed to be 0.58 x mm2/sec in the left and right deep 
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gray matter. 30 minutes after mannitol infusion, the ADC values were 0.5 1 x 10" mm2/sec 
and 0.48 x mm2/sec in the left and right deep gray matter, respectively. The average 
ADC in the left deep gray matter was 0.41 x 1 0-3 mm2/sec after 1 hour, while the right 
deep gray average ADC value remained at 0.48 x mm2/sec. There was no statistically 
significant difference found between the hemispheres at these time points or when 
compared to normal tissue. After 24 hours, the deep gray matter ADC values were 0.53 x 
loe3 mm2/sec in the left hemisphere and 0.61 mm2/sec in the right hemisphere. At 24 
hours, the difference observed between left and right deep gray ADC was statistically 
significant (p<0.05). In addition, both right and left deep gray matter ADC values were 
statistically significant in difference when compared to normal ADC values. The ADC 
values in the left deep gray matter was 0.54 x 1 o - ~  mm2/sec after 48 hours. This difference 
from normal values was statistically significant. After 48 hours, the right deep gray ADC 
returned to the normal value of 0.58 x 10" mm2/sec. Sham-operated rats displayed normal 
ADC at 2 hours and 48 hours post surgery, with no statistically significant differences. 
- 
Light Microscopy 
Brain tissue extracted from cortical and deep gray regions in control, sham- 
operated, and 2 hours post mannitol infusion were observed using light microscopy (LM) 
under hematoxylin and eosin (H&E) staining. Cortical gray regions in the left hemisphere 
contralateral to infusion (Figure 6-11) appeared to contain healthy neurons and normal 
blood vessels when compared to analogous regions in untreated control animals (Figure 6- 
14). In the infused brains, the right hemisphere showed marked differences in structures 
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when compared to the contralateral left hemisphere. As seen in Figure 6-11 B1 and B2, 
the right cortical gray regions contained perivascular spaces surrounding the overwhelming 
majority of blood vessels. Also present were perineuronal spaces surrounding the majority 
of neurons. The neurons themselves appeared to be shrunken and dark in the ipsilateral 
perfused cortical gray matter when compared to the neurons in the contralateral 
hemisphere (Figure 6-11 A1 and A2). Also observed was a spongy appearance in the 
neuropil in the right cortical gray matter, which appeared more uniform and dense in the 
contralateral left cortical gray region. 
In Figure 6-12, similar results are shown for the deep gray matter 
(caudatelputamen) of the mannitol-infused rat brain. These images are from the same rat 
brain as seen in Figure 6-11. As noted earlier, the left hemisphere contralateral to 
mannitol infusion (Figure 6-12 A1 and A2) appears to contain blood vessels and neurons 
that are comparable to those seen in the control deep gray regions. We also see a similar 
perivascular white space surrounding virtually all blood vessels in the deep gray region of 
the right hemisphere (Figure 6-12 B1 and B2). The perineuronal space surrounding dark, 
shrunken neurons were not as prevalent in the ipsilateral right deep gray region when 
compared to the same hemisphere's cortical gray matter. The distributed bundled tracts 
that appear throughout the caudate region are seen as disparate pale regions in the neuropil. 
These bundles appear uniform in the contralateral deep gray matter, but take on an 
irregular appearance in the ipsilateral right caudate region. 
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Representative images of the cortical and deep gray regions in sham-operated rats 
are shown in Figure 6-13. The blood vessels, neurons and overall neuropil appear 
identical to the analogous regions in the untreated control brain shown in Figure 6-14. 
Transmission Electron Microscopy 
Transmission electron nlicroscopy (TEM) was performed on the right cortical gray 
regions of normal rats and in cortical gray regions ipsilateral and contralateral to mannitol 
infusion. Figure 6-15 depicts representative images of blood vessels and neurons in an 
untreated animal and an animal sacrificed 2 hours after the third mannitol infusion (this 
example is from the same rat shown in LM photographs discussed above). The 
contralateral cortical gray structures (Figure 6-15 B and E) appear similar in morphology 
to those found in the control cortical gray matter (Figure 6-15 C and F). 
As seen under LM, there is a marked difference in morphology of the region 
surrounding blood vessels and neurons in the mannitol perfused cortical gray when 
compared to similar regions in the contralateral and control tissue. In perfused tissue, 
perineuronal space observed in LM pictures appears to be swollen processes surrounding 
the neuron as seen in Figure 6-15 A. These white areas appear to be membrane-enclosed 
fluid spaces with free-floating mitochondria. The neuron in Figure 6-15 A also appears to 
have a scalloped shaped due to the surrounding swollen processes. In addition, when 
compared to the contralateral and normal neurons, the neuron located in the right cortical 
gray appears to have a denser cytoplasm. The mitochondria inside the cytoplasm appear 
similar to those in the normal and contralateral neurons. The capillary shown in Figure 6- 
15 D exhibits the perivascular space observed in LM images earlier. Upon closer 
examination, this space may be due to swollen astrocytic processes surrounding the blood 
vessel as evidenced by membrane and mitochondria free floating in the watery spaces. 
The neuropil surrounding the neuron and blood vessel in the perfused tissue 
appears to be more irregular in distribution when compared to contralateral and normal 
tissue. There seem to be a great deal of white spaces in this tissue that can be mostly 
attributed to swollen cellular processes. Figure 6-16 contains images of neuropil 
surrounding blood vessels in the mannitol-perfused and normal tissue, shown previously in 
Figures 6-15 D and F, respectively. Upon closer examination of the neuropil in the 
perfused hemisphere (Figure 6-16 A2) there are white areas which seem to be enclosed by 
cellular process, however, some irregular white regions appear to be fluid-filled space 
which may be ECS. This putative ECS seems to be undistinguishable in the denser 
neuropil of normal tissue (Figure 6-16 B), which appears quite packed and dense in 
appearance. 
Gd-DTPA Infusion 
Figure 6-17 depicts a TI -map representative of gadolinium-diethylene-triamine penta- 
acetic acid (Gd-DTPA) infusion. This image shows a series quantitative T1 map images 
acquired every 10 minutes during the course of a 50 minute Gd-DTPA infusion and 80 
minute follow-up, 130 minutes total. Time 0 shows the normal frontal cortical gray region, 
after which infusion begins as indicated. The Gd-DTPA appears as a dark region in the 
right cortical gray due to the low relaxivity attributed to Gd. The Gd-DTPA appears 
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to be isolated to the right cortical region throughout the infusion, and once infusion ends at 
the 50-minute mark, the Gd-DTPA appears to dissipate based on the observed return to 
baseline contrast. 
Figure 6-17. Time series T1 Map of Gd-DTPA infusion in frontal cortical gray matter of a 
normal brain. Infusion begins at time 0 and ends after 50 minutes, as indicated on the 
diagram. Note infused Gd-DTPA appears as a dark region in right hemisphere due to the 
decrease in T1 value caused by the Gd relaxivity effect. 
CHAPTER 7 
DISCUSSION 
Understanding the dynamics of CED under pathological brain states is vital for 
proper drug targeting and dosage. Previous studies by Haar characterized this convective 
delivery in C E . ~  However, CED under VE proved inconclusive due to limitations 
attributed to the direct infusion VE model.3 Therefore, the current study looked to find a 
better model to study CED in VE conditions. 
The mannitol infusion model of VE was selected to be characterized and evaluated 
for CED study. The mannitol model was modified from two infusions of 25% mannito15' 
to three infusions, based on preliminary studies we conducted in rat brain, using T2W 
imaging as an initial criterion for edema formation. The preliminary studies indicated a 
widespread edema formation through the cortical and deep gray matter, based on 
hyperintensity observed in T2W images. Consistent BBB disruption marked by EB dye 
suggested that this edema was VE in nature. Further MRI studies and histological results 
confirmed a unilateral widespread edema formation in gray matter ipsilateral to mannitol 
perfusion. Details on the characterization of this edema and specific implications for future 
study are discussed below. 
Controls 
The sham-operated animals did not demonstrate changes in ADC values when 
compared to normal untreated brain. Upon hematoxylin and eosin (H&E) staining, 
neurons and blood vessels appeared healthy in the gray matter ipsilateral to the common 
carotid artery (CCA) ligation. This was expected as previous studies have shown no acute 
ischemic effect from sacrificing the right CCA in a rat.'" Our light microscopy (LM) 
results also suggested no ischemic injury from CCA ligation. Therefore, changes observed 
in the right hemisphere ipsilateral to mannitol infusion were due to the mannitol infusion 
specifically. 
Collateral Effects of Mannitol Infusion 
T2W imaging was utilized in preliminary experiments to gauge edema formation 
and led to the selection of the current mannitol model with three infusions. Mortality was 
high in our experiment, as 7 out of the 11 (64%) perfused animals appeared to lose 
spontaneous breathing 2 hours post mannitol infusion. This by itself would imply a high 
degree of toxicity associated with the mannitol infusions. With the marked water levels 
seen with this model, it may be that our initial use of T2 changes for titrating mannitol 
doses to obtain edema development may not provide conditions favorable for animal 
survival. 
Edema formation 
The T2W hyperintensity consistently observed in the cortical and deep gray matter 
was indicative of edema formation in the right hemisphere of the brain, ipsilateral to 
mannitol perfusion. This initial edema formation was seen as soon as 30 minutes after the 
series of mannitol infusions, and is even evident in cortical gray tissue after 24 hours. 
Water maps confirmed the presence of edema with significantly higher water values 
observed in the right hemisphere when compared to the left hemisphere, 30 minutes and 1 
hour after mannitol delivery. Normal human gray and white matter was found to contain 
69% and 80% f,, respectively.145 The current study found gray matter in the rat to have a 
normal average f, of 78%. At 1 hour, water values in edematous deep and cortical gray 
matter demonstrated a 6% to 7% increase in water content compared to the contralateral 
gray matter. Although the increase in water content in the rat brain was extensive, larger 
increases have been observed in other animals and humans. Animals studies by Fatouros 
et al. have observed an increase of water content from the normal 68% seen in the white 
matter of cat brain to 78.6% in edematous white matter using the infusion model of V E . ' ~ ~  
The magnitude of edema increase in cat white matter was larger than what we observed in 
rat gray matter. Given that edematous fluid in the ECS preferentially flows in white 
matter,'" this would be expected. Another study Fatouros and Marmarou found the f, for 
an ROI centered on a human brain tumor to be as high as 86.7% versus 72.1% for the 
contralateral ~ 0 1 . l ~ '  
The water fraction (f,) measured in the averaged gray and deep gray matter 
contralateral to perfusion remained near normal through all time periods. Therefore, the 
observed gray matter edema was localized to the right hemisphere. When observed 
separately, however, the cortical gray matter in the left hemisphere had statistically 
significant high f, observed after 1 hour and 48 hours when compared to normal cortical 
gray water levels. There was a small rise in brain water in the left cortical gray matter, 
despite the lack of cytotoxic injury or BBB disruption as verified by EB dye studies. In 
conjunction with the bilateral hyperintensity observed in T2 images, these observations 
would suggest the possibility of some contralateral flow of edema fluid from the right 
cortical gray matter into the left cortical gray via white matter tracts, and would need to be 
verified by future investigations. Overall, based on water map and T2 analysis, a large 
cortical and deep gray region of edema was created within an hour of the series of mannitol 
infusions and resolved within 48 hours. 
Based on the series of processed T1 maps, the Gd-DTPA appeared to occupy a 
volume of distribution that was enclosed in region of frontal cortex that consistently 
showed T2 hyperintensity in other animals (Figure 7-1 A and C). As seen in Figure 7-1 
B and D, Haar demonstrated Gd-DTPA distribution after CED in the caudatelputamen 
region of normal rat brain that appears to occupy a similar region exhibiting consistent T2 
hyperintensity in our edematous animals.55 Gd-DTPA distribution results seen in the 
frontal cortical gray and Haar's caudate region suggest the current model can be applied to 
CED studies in both areas of the brain. Since this edema was prevalent within an hour of 
infusion, and nearly gone after 24 hours, CED studies using the current model could be 
conducted the same day as mannitol infusion. This model proved to be appropriate for 
CED study in general edematous gray matter. However, further analysis of ADC and 
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histological results were then performed in order to determine whether the observed edema 
demonstrated other important characteristics consistent with VE. 
Characterizing the Edema 
Mannitol delivery via the internal carotid artery (ICA) at the rate we used has been 
shown to produce BBB disruption after just one bolus.9s This is a reversible BBB opening 
that closes within a period of 30  minute^.^' We then reasoned that multiple mannitol 
infusions spaced 30 minutes would create a prolonged opening of the BBB to allow flow 
of proteinaceous fluid into surrounding parenchymal tissue, mimicking the pathological 
state characteristic of VE. EB dye staining prevalent throughout the right hemisphere of the 
brain, ipsilateral to mannitol perfusion, provided qualitative evidence confirming effective 
and extensive BBB disruption. This data was combined with studies of ADC and 
histological changes in order to further characterize the edema. 
Apparent Diffusion Coefficient Map Analysis 
Both echo planar based spin echo (EPI) and spin echo (SE) diffusion weighted 
imaging (DWI) data was collected on rats, 1 hour after mannitol delivery. ADC data 
generated from this data did not show differences between the two types of imaging to be 
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statistically different. ADC response was therefore studied based on EPI DWI alone as it 
was a faster technique and more time-points could be collected. 
VE has been shown to cause an elevation in ADC values, while CE can cause a 
lowering of ADC. Therefore, we would expect to see an elevation of ADC in the 
regions of observed edema in order to characterize the presence of VE. Based on our 
results, the average gray matter ADC values were lower in both hemispheres during the 
first hour of edema formation, although these values were not significantly different from 
normal values. Because a large amount of edema was present at this time point, based on 
T2 and f, analysis, we would have expected ADC values to have been affected more 
significantly, and in the opposite direction than the small, non-significant decrease that was 
observed. This was the first indicator that our model may have contained both CE and VE 
components in the acute phase, thereby pseudonormalizing ADC values. The right 
hemisphere gray matter ADC was slightly but non-significantly higher than the left 
hemisphere after 1 hour and significantly so after 24 hours. At the 24-hour mark, the right 
hemisphere exhibited ADC values that were statistically significantly higher than normal 
tissue. This would be consistent with the presence of some VE effect in that hemisphere, in 
corroboration with the hyperintensity observed in T2W images at the 24 hour time point. 
Given these findings, we went on to perform histological examination of the edematous 
tissue to further investigate these possibilities. 
Microscopy Analysis 
After light microscopy (LM) examination, there appeared to be some cytotoxic 
effect observed in the edematous gray matter under H&E staining. Studies have found that 
cytotoxicity is observed by shrunken neurons with perineuronal spaces: we observed in 
the edematous hemispheres 2 hours post mannitol delivery. Previous studies have also 
shown similar spongy appearance in the neuropil and the appearance of shrunken neurons 
after a single bolus of mannitol perfusion in the rat brain, using the same rate and dose 
used in the current study.136 The spongy appearance of the neuropil and perivascular spaces 
seen under H&E have also been also observed in other edematous tissue where BBB 
disruption occurred. 142;149 
Our histological studies with H&E staining drew concern for injury to cells, with 
the majority of neurons in the perfused gray matter appearing as shrunken and dark in 
appearance, but transmission electron microscopy (TEM) failed to show significant 
evidence of injury to these shrunken neurons. The nucleus of the neurons in the edematous 
tissue appeared healthy, in addition to the presence of healthy-appearing mitochondria 
observed in the cytoplasm. Therefore, the neurons in the mannitol perfused-hemisphere 
appear to have been in a healthy state at the moment of fixation for EM, but the presence 
of swollen processes surrounding the neurons suggest the possibility that these cells could 
be in a beginning phase of degenerat i~n. '~~ The perineuronal space appeared to be 
expanded cellular processes surrounding the neuron, and may have contributed to the 
shrunken appearance of the neurons, whereby processes pushed into the cytoplasm to 
create a scalloped appearance. This may have helped to account for the darker appearance 
of these neurons in the paraffin embedded LM studies as the cytoplasm was being 
compacted. TEM also revealed the perivascular spaces seen under H&E to be swollen 
cellular processes, as opposed to expanded ECS, mostly likely belonging to astrocytes. 
Swollen astrocytic processes surrounding the blood vessels indicate some BBB disruption 
to have occurred'42 as was confirmed earlier by EB dye. The fluid leaking into the ECS 
may have caused hypertonic conditions that could have withdrawn water from the neuron's 
cytoplasm, contributing to neuronal shrinkage. The spongy appearance of the neuropil 
observed in edematous regions under H&E appeared to be due to the swollen cellular 
processes, in addition to putative expansion of ECS. This would indicate an increase in 
both intracellular and extracellular fluid, thereby presenting the possibility of ADC effects 
from the former counteracting with ADC effects from the latter. Further studies would 
need to be conducted to verify that ECS expansion was indeed occurring. 
EB dye in conjunction with perivascular spaces observed under LM and TEM 
revealed BBB disruption, while swollen processes surrounding shrunken neurons suggest 
the presence of mild neurotoxic effects. When examined with our MRI results, the edema 
appears to result from some sort of combination of VE and CE in the acute phase, while 
later (at 24 hours) VE appears to be a dominant portion as evidenced by raised ADC. This 
argues that the edema seen is not a "pure" example of vasogenic effect, but represents a 
combination of VE due to BBB disruption followed by possible cytotoxic effects. 
Conclusion 
Based on our results, our starting hypothesis did not prove all together true; three 
infusions of 25% mannitol did not produce conditions of "pure" VE. We conclude that 
there is an acute phase of extensive edema, which seems to be a mixture of CE and VE, 
which have may a pseudo-normalization effect on the ADC values. The acute edema 
formed within an hour after mannitol infusion was consistent and widespread throughout 
the cortical and deep gray region, and had microscopic and ultrastructural features similar 
to other classic studies of brain edema. We also conclude that this model is applicable for 
CED study in edematous conditions, albeit not in a setting of purely VE. 
The triple mannitol infusion model for edema presented and characterized in this 
study provides a good starting point for further investigations that may lead to a purer 
model of VE. Due to the high mortality, the current model is not robust enough to allow 
for animal survival to enable studies of edema resolution and longer-term consequences of 
the mannitol infusions. Therefore, f~~rther studies will need to investigate changes in 
mannitol dosage that are titrated to changes in ADC values and water content changes, and 
not to T2 changes alone, as were used in the development of this initial model. Indeed, 
further studies have already been initiated, in which early results demonstrate a reduced 
mortality with decreased doses and volumes of mannitol infusion. These results are 
promising for subsequent MRI investigations. 
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